In patients with ankylosing spondylitis, infliximab does not inhibit structural damage, although it may have other beneficial effects, according to European and US researchers. Reuters Health Information
This study reviews therapeutic approaches of direct and indirect B-cell targeting in autoimmune diseases and their impact on protective immunity. Current Opinion in Rheumatology
Expert commentary by Stanley Cohen, MD, on the evidence for benefits and adverse effects of biologic therapies and their most appropriate utilization in different patient groups. Medscape Rheumatology
Like other chronic inflammatory arthropathies, SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome may require long-term antibiotic therapy. Arthritis Research & Therapy
